Andrea Park is a Deputy Editor with a diverse range of writing experience. She has written for publications such as Biotech, Marie Claire, Barron's, Yahoo News UK, and has been featured in Fierce Pharma. Andrea covers a wide range of topics including healthcare, technology, entertainment, and fashion.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
International
Andrea Park's coverage primarily focuses on healthcare and pharmaceuticals, with a significant emphasis on medical devices, FDA approvals/recalls, diabetes management, and health technology. She seems to be particularly interested in innovations within the healthcare industry.
Given her focus on citing data and press releases as well as government announcements related to healthcare and pharmaceuticals topics, she may be receptive to pitches providing exclusive access to new products or treatments backed by credible data or research. Additionally, experts who can offer insights into FDA regulatory processes or trends in health technology adoption could also capture her interest.
While Andrea doesn't have a specified geographic focus, it's important for outreach efforts to align with global trends and developments in the healthcare industry rather than being region-specific.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Andrea Park
Roche's long-awaited challenge to Regeneron's dominance in the ophthalmology market may soon be coming to a head, according to a recent analyst report from GlobalData.
By: Andrea Park
Social media is full of so-called wellness “hacks” that range from the weird but harmless to the downright damaging—and now, Bayer is taking to its own online feeds to battle that misinformation.
By: Andrea Park
In time for Mother’s Day, Genentech released a new Vabysmo ad suggesting that a great way to repay your mother for her years of love and support is with a prescription for the wet age-related macul
By: Andrea Park
Clinical trial names span a broad range, from straightforward acronyms to more inspiring titles—see: Eli Lilly's optimistically dubbed family of
By: Andrea Park
The next Mindy Kaling project? Advocating for people with plaque psoriasis.
By: Andrea Park
With the FDA’s first approval for a treatment for Rett syndrome now under its belt, Daybue make
As it prepares to push its kidney care portfolio out of the nest, Baxter International isn’t branching out too widely with the new company’s branding materials.
By: Andrea Park
AbbVie's newest psoriasis awareness-raising campaign is taking the skin condition out of the spotlight.
By: Andrea Park
The company formerly known as First Wave BioPharma has found itself on dry land with a decidedly non-aquatic new moniker.
By: Andrea Park
Warning: Spoilers for Bridgerton up to season 3, part 1. Ever since Bridgerton debuted on Christmas 2020, the secret of Lady Whistledown's true identity has been the best storyline of the series.
(833) 317-6278 
